Ian Miller
Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1811189061
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $90,590 of the $103,754 with a category attached, or 87.3%. Greenwich Biosciences, Inc. accounts for 76.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $59,410 and has fallen 99.6% since, to $211 in 2025. Among neurology with special qualifications in child neurology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 195 payments — averaging $532.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Greenwich Biosciences, Inc.$80K
- Neurelis, Inc.$13K
- Zogenix Inc.$6K
- Biocodex, Inc.$3K
- UCB GmbH$1K
- Zimmer Biomet$959
- plus $1K from 11 others
Across 125 payments — averaging $8352.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GW Research Limited$639K
- Zogenix Inc.$138K
- Ultragenyx Pharmaceutical Inc.$133K
- UCB Biosciences Inc.$55K
- SK Life Science, Inc.$27K
- Neurelis, Inc.$22K
- plus $31K from 3 others
What the payments were for
- Consulting fees$4,0024%
- Speaking & faculty fees$90,59087%
- Travel & lodging$4,8495%
- Food & beverage$4,3144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Greenwich Biosciences, Inc. | 125 | $79,517 |
| Neurelis, Inc. | 20 | $12,789 |
| Zogenix Inc. | 7 | $5,600 |
| Biocodex, Inc. | 4 | $2,631 |
| UCB GmbH | 9 | $1,165 |
| Zimmer Biomet | 8 | $959 |
| Jazz Pharmaceuticals Inc. | 3 | $383 |
| Neuropace, Inc. | 5 | $228 |
| UCB, Inc. | 3 | $182 |
| Biomarin Pharmaceutical Inc. | 4 | $111 |
| Novartis | 1 | $61 |
| Monteris Medical Corporation | 1 | $43 |
| AstraZeneca | 1 | $24 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $16 |
| Aquestive Therapeutics, Inc. | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$103,754 in reported general payments places this provider in the 90th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Other neurology with special qualifications in child neurology in Miami
- Trevor ResnickMiami$230K
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Matt LallasMiami$88K
- Marytery FajardoMiami$44K
- Paula SchleiferMiami$31K
- Roberto Lopez-AlberolaMiami$31K
- Anuj JayakarMiami$24K
- Walter BradleyMiami$19K
- Yashira Torres RamirezMiami$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.